Research ExplorerJournalsBIOL BLOOD MARROW TR Publications

BIOL BLOOD MARROW TR - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

51 - 87 out of 87Page size: 50

Publications

  1. 2014

  2. Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis

    Gupta, V., Gotlib, J., Radich, J. P., Kröger, N. M., Rondelli, D., Verstovsek, S. & Deeg, H. J., 01.09.2014, In: BIOL BLOOD MARROW TR. 20, 9, p. 1274-81 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

    Hussein, A. A., Halkes, C. M., Socié, G., Tichelli, A., von dem Borne, P. A., Schaap, M. N. P. M., Foa, R., Ganser, A., Dufour, C., Bacigalupo, A., Locasciulli, A., Aljurf, M., Peters, C., Robin, M., van Biezen, A. A., Volin, L., De Witte, T., Marsh, J., Passweg, J. R., Kröger, N-M. & Severe Aplastic Anemia and Chronic Malignancies Working Parties of the European Group for Blood and Marrow Transplantation, 01.09.2014, In: BIOL BLOOD MARROW TR. 20, 9, p. 1448-50 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis

    Kröger, N., Zabelina, T., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., von Huenerbein, N., Kvasnicka, H-M., Thiele, J., Kreipe, H-H. & Büsche, G., 01.06.2014, In: BIOL BLOOD MARROW TR. 20, 6, p. 812-5 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies

    Klyuchnikov, E., El-Cheikh, J., Sputtek, A., Lioznov, M., Calmels, B., Furst, S., Chabannon, C., Crocchiolo, R., Lemarié, C., Faucher, C., Bacher, U., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., Reckhaus, M-L., Blaise, D. & Kröger, N-M., 01.03.2014, In: BIOL BLOOD MARROW TR. 20, 3, p. 382-6 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation

    Alchalby, H., Zabelina, T., Stübig, T., van Biezen, A., Bornhäuser, M., Di Bartolomeo, P., Beelen, D., Cahn, J. Y., Dreger, P., Schroyens, W., de Witte, T., Olavarria, E., Kröger, N. & Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 279-81 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation

    Kröger, N., Stübig, T. & Atanackovic, D., 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 168-72 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Patient, virus, and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program

    Mynarek, M., Ganzenmueller, T., Mueller-Heine, A., Mielke, C., Gonnermann, A., Beier, R., Sauer, M., Eiz-Vesper, B., Kohstall, U., Sykora, K-W., Heim, A. & Maecker-Kolhoff, B., 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 250-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation

    de Lima, M., Porter, D. L., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S. & Schmid, C., 01.01.2014, In: BIOL BLOOD MARROW TR. 20, 1, p. 4-13 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2013

  11. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies

    Avigan, D., Hari, P., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S. & Hsu, K. C., 01.12.2013, In: BIOL BLOOD MARROW TR. 19, 12, p. 1661-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction

    Wayne, A. S., Giralt, S., Kröger, N. & Bishop, M. R., 01.11.2013, In: BIOL BLOOD MARROW TR. 19, 11, p. 1534-6 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  13. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation

    Gress, R. E., Miller, J. S., Battiwalla, M., Bishop, M. R., Giralt, S. A., Hardy, N. M., Kröger, N., Wayne, A. S., Landau, D. A. & Wu, C. J., 01.11.2013, In: BIOL BLOOD MARROW TR. 19, 11, p. 1537-45 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

    Kröger, N-M., Badbaran, A., Zabelina, T., Ayuketang, F. A., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B. & Zander, A. R., 2013, In: BIOL BLOOD MARROW TR. 19, 3, p. 398-404 7 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2012

  16. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.

    Finke, J., Schmoor, C., Bethge, W. A., Ottinger, H. D., Stelljes, M., Zander, A. R., Volin, L., Heim, D. A., Schwerdtfeger, R., Kolbe, K., Mayer, J., Maertens, J. A., Linkesch, W., Holler, E., Koza, V., Bornhäuser, M., Einsele, H., Bertz, H., Grishina, O., Socié, G., ATG-Fresenius Trial Group & Kröger, N-M., 01.11.2012, In: BIOL BLOOD MARROW TR. 18, 11, p. 1716-1726 11 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies.

    Bacher, U., Talano, J-A. & Bishop, M. R., 2012, In: BIOL BLOOD MARROW TR. 18, 1 Suppl, p. 62-73 1 Suppl.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide.

    Malard, F., Kröger, N., Gabriel, I. H., Hübel, K., Apperley, J. F., Basak, G. W., Douglas, K. W., Geraldes, C., Jaksic, O., Koristek, Z., Lanza, F., Lemoli, R., Mikala, G., Selleslag, D., Worel, N., Mohty, M. & Duarte, R. F., 2012, In: BIOL BLOOD MARROW TR. 18, 2, p. 314-317 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2011

  20. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

    Wolff, D., Schleuning, M., von Harsdorf, S., Bacher, U., Gerbitz, A., Stadler, M., Ayuketang Ayuk, F., Kiani, A., Schwerdtfeger, R., Vogelsang, G. B., Kobbe, G., Gramatzki, M., Lawitschka, A., Mohty, M., Pavletic, S. Z., Greinix, H. & Holler, E., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 1-17 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Minimal residual disease following allogeneic hematopoietic stem cell transplantation.

    Kröger, N., Miyamura, K. & Bishop, M. R., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 94-100 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.

    Bishop, M. R., Alyea, E. P., Cairo, M. S., Falkenburg, J. H. F., June, C. H., Kröger, N., Little, R. F., Miller, J. S., Pavletic, S. Z., Porter, D. L., Riddell, S. R., van Besien, K., Wayne, A. S., Weisdorf, D. J., Wu, R. S. & Giralt, S., 2011, In: BIOL BLOOD MARROW TR. 17, 4, p. 443-454 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2010

  25. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

    Porter, D. L., Alyea, E. P., Antin, J. H., DeLima, M., Estey, E., Falkenburg, J. H. F., Hardy, N., Kröger, N., Leis, J., Levine, J., Maloney, D. G., Peggs, K., Rowe, J. M., Wayne, A. S., Giralt, S., Bishop, M. R. & van Besien, K., 01.11.2010, In: BIOL BLOOD MARROW TR. 16, 11, p. 1467-1503 37 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML)

    Klyuchnikov, E., Kröger, N., Brummendorf, T. H., Wiedemann, B., Zander, A. R. & Bacher, U., 01.03.2010, In: BIOL BLOOD MARROW TR. 16, 3, p. 301-10 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML.

    Bacher, U., Haferlach, T., Alpermann, T., Zenger, M., Kröger, N., Beelen, D. W., Kern, W., Schnittger, S. & Haferlach, C., 2010, In: BIOL BLOOD MARROW TR. 16, 12, p. 1649-1657 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

    Wolff, D., Gerbitz, A., Ayuketang Ayuk, F., Kiani, A., Hildebrandt, G. C., Vogelsang, G. B., Elad, S., Lawitschka, A., Socie, G., Pavletic, S. Z., Holler, E. & Greinix, H., 2010, In: BIOL BLOOD MARROW TR. 16, 12, p. 1611-1628 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.

    Bacher, U., Haferlach, C., Kröger, N., Schnittger, S., Kern, W., Wiedemann, B., Zander, A. R. & Haferlach, T., 2010, In: BIOL BLOOD MARROW TR. 16, 1, p. 1-11 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

    Bishop, M. R., Alyea, E. P., Cairo, M. S., Falkenburg, J. H. F., June, C. H., Kröger, N., Little, R. F., Miller, J. S., Pavletic, S. Z., Porter, D., Riddell, S. R., van Besien, K., Wayne, A. S., Weisdorf, D. J., Wu, R. & Giralt, S., 2010, In: BIOL BLOOD MARROW TR. 16, 5, p. 563-564 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.

    Kröger, N., Einsele, H., Derigs, G., Wandt, H., Krüll, A. & Zander, A. R., 2010, In: BIOL BLOOD MARROW TR. 16, 6, p. 861-864 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies.

    Kröger, N., Bacher, U., Bader, P., Böttcher, S., Borowitz, M. J., Dreger, P., Khouri, I., Olavarria, E., Radich, J., Stock, W., Vose, J. M., Weisdorf, D., Willasch, A., Giralt, S., Bishop, M. R. & Wayne, A. S., 2010, In: BIOL BLOOD MARROW TR. 16, 10, p. 1325-1346 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.

    Kröger, N., Bacher, U., Bader, P., Böttcher, S., Borowitz, M. J., Dreger, P., Khouri, I., Macapinlac, H. A., Macapintac, H., Olavarria, E., Radich, J., Stock, W., Vose, J. M., Weisdorf, D., Willasch, A., Giralt, S., Bishop, M. R. & Wayne, A. S., 2010, In: BIOL BLOOD MARROW TR. 16, 9, p. 1187-1211 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2009

  35. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

    Klyuchnikov, E., Kröger, N., Brümmendorf, T., Wiedemann, B., Zander, A. R. & Bacher, U., 2009, In: BIOL BLOOD MARROW TR.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    Kröger, N., Zabelina, T., Binder, T., Ayuketang Ayuk, F., Bacher, U., Amtsfeld, G., Lellek, H., Schrum, J., Erttmann, R., Eiermann, T. & Zander, A. R., 2009, In: BIOL BLOOD MARROW TR. 15, 4, p. 454-462 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Outcome of transplantation for myelofibrosis.

    Ballen, K. K., Shrestha, S., Sobocinski, K. A., Zhang, M-J., Bashey, A., Bolwell, B. J., Cervantes, F., Devine, S. M., Gale, R. P., Gupta, V., Hahn, T. E., Hogan, W. J., Kröger, N., Litzow, M. R., Marks, D. I., Maziarz, R. T., McCarthy, P. L., Schiller, G., Harry, C. S., Roy, V., Wiernik, P. H., Horowitz, M. M., Giralt, S. A. & Arora, M., 2009, In: BIOL BLOOD MARROW TR. *16*, 3, p. 358-367 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. 2008

  39. Cellular immune reconstitution after haploidentical transplantation in children

    Handgretinger, R., Chen, X., Pfeiffer, M., Schumm, M., Müller, I., Feuchtinger, T., Hale, G. & Lang, P., 01.2008, In: BIOL BLOOD MARROW TR. 14, 1 Suppl 1, p. 59-65 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

    Ayuketang Ayuk, F., Diyachenko, G., Zabelina, T., Wolschke, C., Fehse, B., Bacher, U., Erttmann, R., Kröger, N. & Zander, A. R., 2008, In: BIOL BLOOD MARROW TR. 14, 8, p. 913-919 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).

    Platzbecker, U., Bornhäuser, M., Germing, U., Stumpf, J., Scott, B. L., Kröger, N., Schwerdtfeger, R., Böhm, A., Kobbe, G., Theuser, C., Rabitsch, W., Valent, P., Sorror, M. L., Ehninger, G. & Deeg, H. J., 2008, In: BIOL BLOOD MARROW TR. 14, 11, p. 1217-1225 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. 2006

  43. Adoptive transfer of allogeneic antigen-specific T cells

    Riddell, S. R., Bleakley, M., Nishida, T., Berger, C. & Warren, E. H., 01.2006, In: BIOL BLOOD MARROW TR. 12, 1 Suppl 1, p. 9-12 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  44. 2005

  45. Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children

    Eyrich, M., Wollny, G., Tzaribaschev, N., Dietz, K., Brügger, D., Bader, P., Lang, P., Schilbach, K., Winkler, B., Niethammer, D. & Schlegel, P. G., 03.2005, In: BIOL BLOOD MARROW TR. 11, 3, p. 194-205 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. 2004

  47. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

    Kröger, N-M., Perez-Simon, J. A., Myint, H., Klingemann, H., Shimoni, A., Nagler, A., Martino, R., Alegre, A., Tomas, J. F., Schwerdtfeger, R., Kiehl, M., Fauser, A., Sayer, H. G., Leon, A., Beyer, J., Zabelina, T., Ayuketang Ayuk, F., Miguel, S., Jesus, F., Brand, R. & Zander, A., 2004, In: BIOL BLOOD MARROW TR. 10, 10, p. 698-708 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next